Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Liver Diseases

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 291 articles: HTML format

Single Articles

May 2020
1. MA KW, So H, Cho DH, Oh JS, et al
   Durability and outcome of EUS-guided hepaticoduodenostomy using a fully covered metal stent for segregated right intrahepatic duct dilatation.
   J Gastroenterol Hepatol. 2020 May 4. doi: 10.1111/jgh.15089.
   PubMed     Abstract available
   
   
   
2. KOBAYASHI T, Kanno K, Nguyen PT, Sugiyama A, et al
   Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of nonalcoholic steatohepatitis.
   J Gastroenterol Hepatol. 2020 May 4. doi: 10.1111/jgh.15088.
   PubMed     Abstract available
   
   
   
3. YANG C, Yang H, Deng S, Zhang Y, et al
   Hepatobiliary and Pancreatic: Hepatic cystadenoma mimics hepatic cystic echinococcsis.
   J Gastroenterol Hepatol. 2020 May 3. doi: 10.1111/jgh.15044.
   PubMed    
   
   
   April 2020
4. YIP TC, Wong GL, Chan HL, Tse YK, et al
   Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus.
   J Gastroenterol Hepatol. 2020 Apr 28. doi: 10.1111/jgh.15079.
   PubMed     Abstract available
   
   
   
5. TSENG CH, Tseng CM, Wu JL, Hsu YC, et al
   Magnitude of and Prediction for Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Taking Entecavir or Tenofovir Therapy: A Systematic Review.
   J Gastroenterol Hepatol. 2020 Apr 28. doi: 10.1111/jgh.15078.
   PubMed     Abstract available
   
   
   
6. MAZIDI M, Ofori-Asenso R, Kengne AP
   Dietary Patterns Are Associated with Likelihood of Hepatic Steatosis among US Adults.
   J Gastroenterol Hepatol. 2020 Apr 26. doi: 10.1111/jgh.15076.
   PubMed     Abstract available
   
   
   
7. WANG Y, Shen J, Feng S, Liang R, et al
   Hepatic Resection versus Transarterial Chemoembolization in Infiltrative Hepatocellular Carcinoma: A Multicenter Study.
   J Gastroenterol Hepatol. 2020 Apr 4. doi: 10.1111/jgh.15060.
   PubMed     Abstract available
   
   
   
8. OGURA T, Nishioka N, Ueno S, Yamada M, et al
   Guidewire insertion under transluminal cholangioscopy guidance for a hepaticojejunostomy stricture resembling a pinhole (with video).
   J Gastroenterol Hepatol. 2020 Apr 4. doi: 10.1111/jgh.15050.
   PubMed    
   
   
   March 2020
9. KIM JH, Kang SH, Lee M, Choi HS, et al
   Improved Detection of Hepatocellular Carcinoma by Dynamic CT in Cirrhotic Patients With Chronic Hepatitis B: A Multi-Center Study.
   J Gastroenterol Hepatol. 2020 Mar 28. doi: 10.1111/jgh.15046.
   PubMed     Abstract available
   
   
   
10. TERASHIMA T, Honda M, Toyama T, Shimakami T, et al
    IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
    J Gastroenterol Hepatol. 2020 Mar 16. doi: 10.1111/jgh.15035.
    PubMed     Abstract available
    
    
    
11. GU L, Yao Q, Shen Z, He Y, et al
    Comparison of TDF versus ETV on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2020 Mar 16. doi: 10.1111/jgh.15036.
    PubMed     Abstract available
    
    
    
12. HA I, Chung JW, Jang ES, Jeong SH, et al
    Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
    J Gastroenterol Hepatol. 2020 Mar 10. doi: 10.1111/jgh.15031.
    PubMed     Abstract available
    
    
    
13. VENKATESH V, Rana SS, Kumar A, Aneja A, et al
    Hepatobiliary and Pancreatic: EUS-guided drainage of a ruptured amoebic liver abscess in a child.
    J Gastroenterol Hepatol. 2020 Mar 6. doi: 10.1111/jgh.15014.
    PubMed    
    
    
    
14. WU HM, Ni XX, Xu QY, Wang Q, et al
    Regulation of lipid-induced macrophage polarization through modulating PPAR-gamma activity affects hepatic lipid metabolism via TLR4/NF-kappaB signaling pathway.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15025.
    PubMed     Abstract available
    
    
    
15. DALAL I, Cristelli R, Shahid H, Patel AV, et al
    Hepatobiliary and Pancreatic: Ectopic pancreas presented as a large paragastric mass.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15013.
    PubMed    
    
    
    
16. YOON JS, Lee HY, Chung SW, Kim SW, et al
    Prognostic impact of concurrent non-alcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15026.
    PubMed     Abstract available
    
    
    
17. QIAN Y, Liu F, Zhang W, Zheng X, et al
    AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of HIF-1alpha expression under hypoxia.
    J Gastroenterol Hepatol. 2020 Mar 1. doi: 10.1111/jgh.15023.
    PubMed     Abstract available
    
    
    February 2020
18. PARK S, Jung J, Cho B, Kim SY, et al
    Clinical Outcomes of Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2020 Feb 13. doi: 10.1111/jgh.15011.
    PubMed     Abstract available
    
    
    
19. LIU M, Shi J, Mu T, Wang Y, et al
    A systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
    J Gastroenterol Hepatol. 2020 Feb 13. doi: 10.1111/jgh.15010.
    PubMed     Abstract available
    
    
    
20. WALLACE MC, Samuelson S, Khoo T, Ooi J, et al
    The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
    J Gastroenterol Hepatol. 2020 Feb 9. doi: 10.1111/jgh.15008.
    PubMed     Abstract available
    
    
    
21. ISHIZUKA K, Kon K, Lee HC, Arai K, et al
    Aging exacerbates high-fat diet-induced steatohepatitis through alteration in hepatic lipid metabolism in mice.
    J Gastroenterol Hepatol. 2020 Feb 6. doi: 10.1111/jgh.15006.
    PubMed     Abstract available
    
    
    
22. YUE F, Xia K, Wei L, Xing L, et al
    Constant light exposure causes dysregulation of sphingolipids and promotes steatohepatitis in high-fat fed rats.
    J Gastroenterol Hepatol. 2020 Feb 6. doi: 10.1111/jgh.15005.
    PubMed     Abstract available
    
    
    January 2020
23. IWANO K, Kurita A, Yazumi S
    Hepatobiliary and Pancreatic: Follicular cholangitis mimicking perihilar cholangiocarcinoma.
    J Gastroenterol Hepatol. 2020 Jan 28. doi: 10.1111/jgh.14966.
    PubMed    
    
    
    
24. PATERNOSTRO R, Kapzan L, Mandorfer M, Schwarzer R, et al
    Anemia and iron deficiency in compensated and decompensated cirrhosis: prevalence and impact on clinical outcomes.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14988.
    PubMed     Abstract available
    
    
    
25. KOGISO T, Sagawa T, Kodama K, Taniai M, et al
    Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14989.
    PubMed     Abstract available
    
    
    
26. KIRINO S, Tamaki N, Kaneko S, Kurosaki M, et al
    Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14990.
    PubMed     Abstract available
    
    
    
27. SUGIURA R, Kinoshita K, Naruse H, Yamamoto Y, et al
    Hepatobiliary and Pancreatic: Hemosuccus pancreaticus due to an intraductal papillary mucinous neoplasm: A rare cause of obscure gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2020 Jan 20. doi: 10.1111/jgh.14881.
    PubMed    
    
    
    
28. TOYODA H, Atsukawa M, Watanabe T, Nakamuta M, et al
    Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic HCV infection in a real-word setting: a large, multicenter study from Japan.
    J Gastroenterol Hepatol. 2020 Jan 16. doi: 10.1111/jgh.14982.
    PubMed     Abstract available
    
    
    
29. XIE JM, Li W, Chen W
    Hepatobiliary and pancreatic: A case of stone-like carcinosarcoma in common bile duct.
    J Gastroenterol Hepatol. 2020 Jan 14. doi: 10.1111/jgh.14967.
    PubMed    
    
    
    
30. FUJIKAWA H, Araki M
    Hepatobiliary and Pancreatic: Abscess of the ligamentum teres hepatis.
    J Gastroenterol Hepatol. 2020 Jan 3. doi: 10.1111/jgh.14921.
    PubMed    
    
    
    
31. DAIJO K, Nakahara T, Inagaki Y, Nanba M, et al
    Risk factors for histological progression of nonalcoholic steatohepatitis analyzed from repeated biopsy cases.
    J Gastroenterol Hepatol. 2020 Jan 2. doi: 10.1111/jgh.14968.
    PubMed     Abstract available
    
    
    December 2019
32. ATSUKAWA M, Tsubota A, Takaguchi K, Toyoda H, et al
    Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
    J Gastroenterol Hepatol. 2019 Dec 27. doi: 10.1111/jgh.14965.
    PubMed     Abstract available
    
    
    
33. LI Y, Zhang Y, Chen T, Huang Y, et al
    Aldosterone induces activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
    J Gastroenterol Hepatol. 2019 Dec 20. doi: 10.1111/jgh.14961.
    PubMed     Abstract available
    
    
    
34. SUDA T, Shirota Y, Hodo Y, Wakabayashi T, et al
    Hepatobiliary and Pancreatic: Intraductal papillary mucinous neoplasm rupture: A rare cause of pancreatic fistula.
    J Gastroenterol Hepatol. 2019 Dec 10. doi: 10.1111/jgh.14882.
    PubMed    
    
    
    
35. SOHN W, Kim JH, Cho JY
    Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria.
    J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1111/jgh.14871.
    PubMed     Abstract available
    
    
    
36. TAKATA K, Matsumoto K, Hirai F
    Hepatobiliary and Pancreatic: An intraperitoneal gallstone due to gallbladder perforation.
    J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1111/jgh.14918.
    PubMed    
    
    
    November 2019
37. LIN HH, Liao SH, Huang YL, Liu KL, et al
    Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts.
    J Gastroenterol Hepatol. 2019 Nov 11. doi: 10.1111/jgh.14821.
    PubMed    
    
    
    
38. HUANG WC, Liau JY, Jeng YM, Liu KL, et al
    Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
    J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1111/jgh.14903.
    PubMed     Abstract available
    
    
    
39. VARELAS LJ, Klinge MJ, Malik SM, Borhani AA, et al
    IDIOPATHIC PNEUMATOSIS INTESTINALIS SECONDARY TO LACTULOSE USE IN PATIENTS WITH CIRRHOSIS.
    J Gastroenterol Hepatol. 2019 Nov 6. doi: 10.1111/jgh.14920.
    PubMed     Abstract available
    
    
    
40. WU CK, Yang SC, Liang CM, Li YC, et al
    The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14873.
    PubMed     Abstract available
    
    
    October 2019
41. TOBARI M, Hashimoto E, Taniai M, Kodama K, et al
    The characteristics and risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis.
    J Gastroenterol Hepatol. 2019 Oct 9. doi: 10.1111/jgh.14867.
    PubMed     Abstract available
    
    
    September 2019
42. ZHAO S, Xu W, Xie YX, Chen WW, et al
    CXCR5(+) CD4(+) T cell subsets and their relationship to immune dysfunction in chronic hepatitis B associated liver cirrhosis.
    J Gastroenterol Hepatol. 2019 Sep 13. doi: 10.1111/jgh.14866.
    PubMed     Abstract available
    
    
    
43. CHA SW, Kim SH, Kim YT, Sohn JH, et al
    Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Sep 4. doi: 10.1111/jgh.14848.
    PubMed     Abstract available
    
    
    
44. ZHONG Y, Peng S, Yang Y
    Hepatobiliary and Pancreatic: Caroli syndrome: Egg-like sign on CT.
    J Gastroenterol Hepatol. 2019 Sep 1. doi: 10.1111/jgh.14822.
    PubMed    
    
    
    
45. LIU C, Ma L, Wang J, Li F, et al
    Prophylactic use of antibiotics in endoscopic injection of tissue adhesive for the elective treatment of gastric varices: A randomized controlled study.
    J Gastroenterol Hepatol. 2019;34:1486-1491.
    PubMed     Abstract available
    
    
    
46. HEUCKE N, Wuensch T, Mohr J, Kaffarnik M, et al
    Non-invasive structure-function assessment of the liver by 2D time-harmonic elastography and the dynamic Liver MAximum capacity (LiMAx) test.
    J Gastroenterol Hepatol. 2019;34:1611-1619.
    PubMed     Abstract available
    
    
    
47. KANG MK, Park JG, Lee HJ, Kim MC, et al
    Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2019;34:1633-1640.
    PubMed     Abstract available
    
    
    August 2019
48. SOBOTKA LA, Risaliti C, Hinton A, Michaels A, et al
    Management of Hepatic Hydrothorax and Effect on Length of Stay, Mortality, Cost, and 30-Day Hospital Readmission.
    J Gastroenterol Hepatol. 2019 Aug 23. doi: 10.1111/jgh.14842.
    PubMed     Abstract available
    
    
    
49. FENG Q, Yao J
    Hepatobiliary and Pancreatic: common bile duct stones with situs inversus totalis.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14833.
    PubMed    
    
    
    
50. PANDYA K, Liu K, Strasser SI
    Diaphragmatic paralysis after transarterial chemoembolization of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14834.
    PubMed    
    
    
    
51. SAWADA Y, Kawaratani H, Kubo T, Fujinaga Y, et al
    Effect of furosemide on muscle cramps in patients with liver cirrhosis.
    J Gastroenterol Hepatol. 2019 Aug 5. doi: 10.1111/jgh.14820.
    PubMed     Abstract available
    
    
    
52. PURCELL Y, Sartoris R, Paradis V, Vilgrain V, et al
    Influence of pre-treatment Tumour Growth Rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization.
    J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14816.
    PubMed     Abstract available
    
    
    
53. WONG GL, Wong VW
    Non-alcoholic fatty liver disease in Asia: How is it different from the West?
    J Gastroenterol Hepatol. 2019;34:1267-1268.
    PubMed    
    
    
    
54. RIDDIOUGH GE, Fifis T, Muralidharan V, Perini MV, et al
    Searching for the link; mechanisms underlying liver regeneration and recurrence of colorectal liver metastasis post partial hepatectomy.
    J Gastroenterol Hepatol. 2019;34:1276-1286.
    PubMed     Abstract available
    
    
    
55. FUJII H, Imajo K, Yoneda M, Nakahara T, et al
    HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2019;34:1390-1395.
    PubMed     Abstract available
    
    
    
56. LAI LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, et al
    Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    J Gastroenterol Hepatol. 2019;34:1396-1403.
    PubMed     Abstract available
    
    
    
57. TOMENO W, Imajo K, Kuwada Y, Ogawa Y, et al
    Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.
    J Gastroenterol Hepatol. 2019;34:1411-1416.
    PubMed     Abstract available
    
    
    
58. DARWEESH SK, Abd Alziz RA, Omar H, Sabry D, et al
    Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2019;34:1424-1431.
    PubMed     Abstract available
    
    
    July 2019
59. LEAO GS, Neto GJ, de Freitas Jotz R, Alves de Mattos AA, et al
    Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis.
    J Gastroenterol Hepatol. 2019 Jul 28. doi: 10.1111/jgh.14791.
    PubMed     Abstract available
    
    
    
60. KOBAYASHI T, Yoshikawa S, Takeuchi M, Terai S, et al
    Hepatobiliary and Pancreatic: AL amyloidosis presented as a hematoma in the hepatoduodenal ligament.
    J Gastroenterol Hepatol. 2019 Jul 24. doi: 10.1111/jgh.14744.
    PubMed    
    
    
    
61. GUPTA T, Lochan D, Verma N, Rathi S, et al
    Presence of Multidrug-resistant Infections at Admission Predict 28-day mortality in Acute Decompensation of Cirrhosis.
    J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14788.
    PubMed     Abstract available
    
    
    
62. GUEDES TP, Fernandes B, Pedroto I
    Hepatobiliary and Pancreatic: Symptomatic hepatic splenosis.
    J Gastroenterol Hepatol. 2019 Jul 18. doi: 10.1111/jgh.14743.
    PubMed    
    
    
    
63. YANG MJ, Lee GH, Kim JH, Hwang JC, et al
    Hepatobiliary and Pancreatic: Management of a benign bilio-enteric stricture by a novel covered stent with a long lasso.
    J Gastroenterol Hepatol. 2019 Jul 9. doi: 10.1111/jgh.14747.
    PubMed    
    
    
    
64. NISHIKAWA Y, Hirata A, Uza N
    Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with intratumoral calcification mimicking hepatolithiasis.
    J Gastroenterol Hepatol. 2019 Jul 7. doi: 10.1111/jgh.14726.
    PubMed    
    
    
    
65. PATEL K, Mumtaz K, Li F, Luthra A, et al
    Index Admission Cholecystectomy for Acute Biliary Pancreatitis Favorably Impacts Outcomes of Hospitalization in Cirrhosis.
    J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14775.
    PubMed     Abstract available
    
    
    
66. IWAMOTO T, Maeda M, Saeki I, Hidaka I, et al
    Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites.
    J Gastroenterol Hepatol. 2019;34:1231-1235.
    PubMed     Abstract available
    
    
    
67. SAKAMOTO N, Suda G, Morikawa K, Ogawa K, et al
    Nutrition is often ignored in management of chronic liver diseases.
    J Gastroenterol Hepatol. 2019;34:1127-1128.
    PubMed    
    
    
    June 2019
68. ABBASNEZHAD A, Choghakhori R, Kashkooli S, Aalipour M, et al
    Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2019 Jun 29. doi: 10.1111/jgh.14765.
    PubMed     Abstract available
    
    
    
69. ZHU S, Du L, Xu D, Lu Z, et al
    Ascitic Fluid Total Protein, a useful marker in non-portal hypertensive ascites.
    J Gastroenterol Hepatol. 2019 Jun 27. doi: 10.1111/jgh.14768.
    PubMed     Abstract available
    
    
    
70. REKIK S, Allaire M, Mumana A, Guyot E, et al
    Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.
    J Gastroenterol Hepatol. 2019 Jun 24. doi: 10.1111/jgh.14763.
    PubMed     Abstract available
    
    
    
71. SUN X, Ge X, Xu Z, Chen D, et al
    Identification of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma by integrated analysis.
    J Gastroenterol Hepatol. 2019 Jun 20. doi: 10.1111/jgh.14762.
    PubMed     Abstract available
    
    
    
72. LIU J, Shi Q, Xiao SP, Zhou C, et al
    Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
    J Gastroenterol Hepatol. 2019 Jun 20. doi: 10.1111/jgh.14761.
    PubMed     Abstract available
    
    
    
73. KURAMOTO K, Beppu T, Irie K, Kinoshita K, et al
    Hepatobiliary and Pancreatic: Intra-ductal biliary schwannoma.
    J Gastroenterol Hepatol. 2019 Jun 18. doi: 10.1111/jgh.14679.
    PubMed    
    
    
    
74. KIDA A, Matsuda K, Matsuda M, Sakai A, et al
    Hepatobiliary and Pancreatic: Biliary injury related to checkpoint inhibitor "pembrolizumab".
    J Gastroenterol Hepatol. 2019 Jun 14. doi: 10.1111/jgh.14677.
    PubMed    
    
    
    
75. KIM TS, Sinn DH, Kang W, Gwak GY, et al
    Hepatitis B virus DNA levels and overall survival in hepatitis B related hepatocellular carcinoma patients with low-level viremia.
    J Gastroenterol Hepatol. 2019 Jun 3. doi: 10.1111/jgh.14750.
    PubMed     Abstract available
    
    
    
76. TADA T, Kumada T, Toyoda H, Tsuji K, et al
    Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
    J Gastroenterol Hepatol. 2019;34:1066-1073.
    PubMed     Abstract available
    
    
    May 2019
77. ZHANG RG, Tian X, Jia Q, Meng ZW, et al
    Hepatobiliary and Pancreatic: Chest tightness as a manifestation of cardiac metastasis related to hepatoma.
    J Gastroenterol Hepatol. 2019 May 29. doi: 10.1111/jgh.14680.
    PubMed    
    
    
    
78. MUDALIAR S, Liu K, Pavendranathan G, Kench JG, et al
    Hepatobiliary and Pancreatic: Kasabach-Merritt syndrome in adult.
    J Gastroenterol Hepatol. 2019 May 28. doi: 10.1111/jgh.14676.
    PubMed    
    
    
    
79. DEZSO K, Nagy P, Paku S
    Human liver regeneration following massive hepatic necrosis - two distinct patterns.
    J Gastroenterol Hepatol. 2019 May 14. doi: 10.1111/jgh.14721.
    PubMed     Abstract available
    
    
    
80. SU TH, Liao SH, Hong CM, Liu CJ, et al
    NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
    J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14705.
    PubMed     Abstract available
    
    
    
81. SEMMLER G, Simbrunner B, Scheiner B, Schwabl P, et al
    Impact of farnesoid X receptor SNPs on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
    J Gastroenterol Hepatol. 2019 May 6. doi: 10.1111/jgh.14700.
    PubMed     Abstract available
    
    
    
82. IDA S, Kojima Y, Hamaoka S, Urawa N, et al
    Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2019;34:947-953.
    PubMed     Abstract available
    
    
    April 2019
83. JIANG X, Liu F, Wang Y, Gao J, et al
    SPARC promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancer stem cell phenotypes.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14692.
    PubMed     Abstract available
    
    
    
84. ZHANG C, Ge S, Wang J, Jing X, et al
    Epigenomic Profiling of DNA Methylation Reveals New Potential Biomarkers for Hepatocellular Carcinoma Diagnosis and Prognosis Prediction.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14694.
    PubMed     Abstract available
    
    
    
85. XIANG Q, Zhou D, He X, Fan J, et al
    The zinc finger protein GATA4 induces MET and cellular senescence through the NF-kappaB pathway in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Apr 17. doi: 10.1111/jgh.14684.
    PubMed     Abstract available
    
    
    
86. WATSON H, Guevara M, Vilstrup H, Gines P, et al
    Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
    J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683.
    PubMed     Abstract available
    
    
    
87. HU KS, Tang B, Yuan J, Lu SX, et al
    A new sub-stage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14673.
    PubMed     Abstract available
    
    
    
88. LIU CH, Shih YL, Yang SS, Lin CL, et al
    Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East-Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.
    J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14672.
    PubMed     Abstract available
    
    
    March 2019
89. CHEN CJ, Wang LC, Kuo HT, Fang YC, et al
    Late-evening snacking improves liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14665.
    PubMed     Abstract available
    
    
    
90. FOUAD TR, Abdelsameea E, Abdel-Razek W, Attia A, et al
    Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators.
    J Gastroenterol Hepatol. 2019 Mar 14. doi: 10.1111/jgh.14659.
    PubMed     Abstract available
    
    
    
91. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis Diagnosis of NASH using serum fatty acid.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14654.
    PubMed     Abstract available
    
    
    
92. ZENG X, Li XX, Shi PM, Zhang YY, et al
    Utility of the EncephalApp Stroop Test for Covert Hepatic Encephalopathy Screening in Chinese Cirrhotic Patients.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14656.
    PubMed     Abstract available
    
    
    
93. ROSSI UG, Rutigliani M, DeCensi A
    Hepatobiliary and Pancreatic: Sub-Glisson's capsule hepatic multiple nodular formations.
    J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1111/jgh.14618.
    PubMed    
    
    
    
94. YAMATO M, Sakai Y, Mochida H, Kawaguchi K, et al
    Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    J Gastroenterol Hepatol. 2019 Mar 3. doi: 10.1111/jgh.14647.
    PubMed     Abstract available
    
    
    
95. KUK N, Hodge A, Sun Y, Correia J, et al
    Human amnion epithelial cells and their soluble factors reduce liver fibrosis in a murine non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2019 Mar 1. doi: 10.1111/jgh.14643.
    PubMed     Abstract available
    
    
    
96. TEOH NC
    Recent advances in the management of hepatocellular carcinoma: First, cut ... is the deepest or is it "no-touch" and exercise?
    J Gastroenterol Hepatol. 2019;34:481-482.
    PubMed    
    
    
    
97. KOBAYAKAWA M, Ohnishi S, Suzuki H
    Recent development of balloon-occluded retrograde transvenous obliteration.
    J Gastroenterol Hepatol. 2019;34:495-500.
    PubMed     Abstract available
    
    
    February 2019
98. MAK LY, Ko M, To E, Wong DK, et al
    Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2019 Feb 20. doi: 10.1111/jgh.14637.
    PubMed     Abstract available
    
    
    
99. HANAI T, Shiraki M, Watanabe S, Imai K, et al
    Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: a propensity score-matching analysis.
    J Gastroenterol Hepatol. 2019 Feb 18. doi: 10.1111/jgh.14635.
    PubMed     Abstract available
    
    
    
100. LAI-HUNG WONG G, Sung JJ
     The emerging role of big data in gastroenterology and hepatology.
     J Gastroenterol Hepatol. 2019;34:307-308.
     PubMed    
     
     
     January 2019
101. ZHUGE Y, Liu Y, Xie W, Zou X, et al
     Expert consensus on the clinical management of pyrrolizidine alkaloid induced hepatic sinusoidal obstruction syndrome.
     J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14612.
     PubMed     Abstract available
     
     
     
102. KODAMA K, Kawaguchi T, Hyogo H, Nakajima T, et al
     Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
     J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14608.
     PubMed     Abstract available
     
     
     
103. LOHANA AK, Abid S, Sayani R, Tahir U, et al
     Hepatobiliary and Pancreatic: Bleeding in amyloid liver: A rare presentation of primary liver amyloidosis.
     J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14567.
     PubMed    
     
     
     
104. TAKAHASHI K, Ozawa E, Nakao K, Aoki S, et al
     Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
     J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14568.
     PubMed    
     
     
     
105. SUNG J
     Renaissance in gastroenterology and hepatology.
     J Gastroenterol Hepatol. 2019;34:5-6.
     PubMed    
     
     
     
106. ITO T, Ishigami M, Ishizu Y, Kuzuya T, et al
     Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
     J Gastroenterol Hepatol. 2019;34:207-214.
     PubMed     Abstract available
     
     
     
107. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
     Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
     J Gastroenterol Hepatol. 2019;34:215-223.
     PubMed     Abstract available
     
     
     
108. LI C, Guo P, Okekunle AP, Ji X, et al
     Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
     J Gastroenterol Hepatol. 2019;34:256-262.
     PubMed     Abstract available
     
     
     
109. CHOW JC, Wong GL, Chan AW, Shu SS, et al
     Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
     J Gastroenterol Hepatol. 2019;34:241-248.
     PubMed     Abstract available
     
     
     December 2018
110. TOBARI M, Hashimoto E, Taniai M, Ikarashi Y, et al
     Characteristics of nonalcoholic steatohepatitis among lean patients in Japan: not uncommon and not always benign.
     J Gastroenterol Hepatol. 2018 Dec 27. doi: 10.1111/jgh.14585.
     PubMed     Abstract available
     
     
     
111. LOPEZ RN, Al Rawahi Y, Stormon M, Chennapragada M, et al
     Hepatobiliary and Pancreatic: Hepatic arterioportal fistula: A novel and treatable feature of Alagille syndrome.
     J Gastroenterol Hepatol. 2018 Dec 18. doi: 10.1111/jgh.14506.
     PubMed    
     
     
     
112. ASPELUND G, Mahdi EM, Rothstein DH, Wakeman DS, et al
     Transitional care for patients with surgical pediatric hepatobiliary disease: choledochal cysts and biliary atresia.
     J Gastroenterol Hepatol. 2018 Dec 15. doi: 10.1111/jgh.14575.
     PubMed     Abstract available
     
     
     
113. TEJEDOR-TEJADA J, Garcia-Pajares F, Madrigal Rubiales B
     Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
     J Gastroenterol Hepatol. 2018 Dec 9. doi: 10.1111/jgh.14503.
     PubMed    
     
     
     November 2018
114. BOSSEN L, Gines P, Vilstrup H, Watson H, et al
     Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites.
     J Gastroenterol Hepatol. 2018 Nov 30. doi: 10.1111/jgh.14558.
     PubMed     Abstract available
     
     
     
115. DEPREZ N, Dedeurwaerdere F, Desomer L, De Wulf D, et al
     Hepatobiliary and Pancreatic: Pyoderma gangrenosum of the pancreas successfully treated with infliximab.
     J Gastroenterol Hepatol. 2018 Nov 22. doi: 10.1111/jgh.14504.
     PubMed    
     
     
     
116. SUN Y, Lan X, Shao C, Wang T, et al
     Clinical Features of Idiopathic Portal Hypertension in China: A Retrospective Study of 338 Patients and Literature Review.
     J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14552.
     PubMed     Abstract available
     
     
     
117. WAKIZAKA K, Yokoo H, Kamiyama T, Ohira M, et al
     Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
     J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14547.
     PubMed     Abstract available
     
     
     
118. CHEN ZY, Liu YP, Zhou DJ
     Hepatobiliary and Pancreatic: Glycogenic hepatopathy in a patient with poorly controlled diabetes mellitus mimics a hepatic neoplasm.
     J Gastroenterol Hepatol. 2018 Nov 15. doi: 10.1111/jgh.14505.
     PubMed    
     
     
     
119. CAN SEZGIN G, Deniz K, Karahan OI, Gursoy S, et al
     Hepatobiliary and Pancreatic: Sclerosing extramedullary hematopoietic tumor involving hepatic hilum.
     J Gastroenterol Hepatol. 2018 Nov 12. doi: 10.1111/jgh.14507.
     PubMed    
     
     
     
120. CHENG YQ, Wang K, Zhang XP, Wei XB, et al
     Thrombocytopenia: a prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
     J Gastroenterol Hepatol. 2018 Nov 7. doi: 10.1111/jgh.14537.
     PubMed     Abstract available
     
     
     
121. KOYA S, Kawaguchi T, Hashida R, Hirota K, et al
     Effects of In-Hospital Exercise on Sarcopenia in Hepatoma Patients Who Underwent Transcatheter Arterial Chemoembolization.
     J Gastroenterol Hepatol. 2018 Nov 7. doi: 10.1111/jgh.14538.
     PubMed     Abstract available
     
     
     
122. ADACHI T, Nouso K, Miyahara K, Oyama A, et al
     Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.
     J Gastroenterol Hepatol. 2018 Nov 6. doi: 10.1111/jgh.14535.
     PubMed     Abstract available
     
     
     
123. DASHPUTRE AA, Nemecek BD, Kamal KM, Covvey JR, et al
     The relationship between a cirrhosis-specific comorbidity scoring system and healthcare utilization patterns.
     J Gastroenterol Hepatol. 2018 Nov 5. doi: 10.1111/jgh.14531.
     PubMed     Abstract available
     
     
     
124. 
     Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15-18 November 2018.
     J Gastroenterol Hepatol. 2018;33 Suppl 4:6-565.
     PubMed    
     
     
     October 2018
125. SOBOTKA LA, Hinton A, Conteh LF
     Disparities in the Treatment of Hepatocellular Carcinoma Based on Geographical Region Are Decreasing.
     J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14515.
     PubMed     Abstract available
     
     
     
126. GYODA Y, Imamura H, Ichida H, Yoshimoto J, et al
     Significance of hypovascular lesions on dynamic CT and/or EOB-enhanced MRI in patients with hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14510.
     PubMed     Abstract available
     
     
     
127. ALLER MA, Arias N, Blanco-Rivero J, Arias JL, et al
     Hepatic encephalopathy: Sometimes more portal than hepatic.
     J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14514.
     PubMed     Abstract available
     
     
     
128. COOL J, Rosenblatt R, Kumar S, Lucero C, et al
     PORTAL VEIN THROMBOSIS PREVALENCE AND ASSOCIATED MORTALITY IN CIRRHOSIS IN A NATIONALLY REPRESENTATIVE INPATIENT COHORT.
     J Gastroenterol Hepatol. 2018 Oct 11. doi: 10.1111/jgh.14501.
     PubMed     Abstract available
     
     
     
129. OGAWA Y, Honda Y, Kessoku T, Tomeno W, et al
     Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2018;33:1795-1803.
     PubMed     Abstract available
     
     
     September 2018
130. HIROOKA M, Hiraoka A, Ochi H, Koizumi Y, et al
     No-touch radiofrequency ablation is an ideal method to prevent intrahepatic metastasis of hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14476.
     PubMed     Abstract available
     
     
     
131. MOLLER S, La Cour Sibbesen E, Madsen JL, Bendtsen F, et al
     The indocyanine green retention test in cirrhosis and portal hypertension. Accuracy and relation to severity of disease.
     J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14470.
     PubMed     Abstract available
     
     
     
132. LU J, Xiong XZ, Cheng NS
     Hepatobiliary and Pancreatic: Inflammatory myofibroblastic tumor of the liver mimicking intrahepatic cholangiocarcinoma with hilar lymph node metastasis.
     J Gastroenterol Hepatol. 2018 Sep 14. doi: 10.1111/jgh.14444.
     PubMed    
     
     
     
133. XU X, Cong L, Zhao Y
     Hepatobiliary and Pancreatic: Tumor to tumor metastasis from a primary insulinoma to a hepatic adenoma.
     J Gastroenterol Hepatol. 2018 Sep 6. doi: 10.1111/jgh.14443.
     PubMed    
     
     
     August 2018
134. KAKISAKA K, Suzuki Y, Fujiwara Y, Suzuki A, et al
     Lysophosphatidylcholine acyltransferase 3 is decreased in non-alcoholic steatohepatitis, resulting in caspase-independent hepatocyte death.
     J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14461.
     PubMed     Abstract available
     
     
     
135. KOZUKA R, Enomoto M, Sato-Matsubara M, Yoshida K, et al
     HLA-DQA1/DRB1 Polymorphism is Associated with the Development of Hepatocellular Carcinoma during Entecavir Treatment.
     J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14454.
     PubMed     Abstract available
     
     
     
136. KHAN F, Parikh MP, McCullough AJ
     Hepatobiliary and Pancreatic: Mauriac syndrome: A rare cause of elevated liver enzymes.
     J Gastroenterol Hepatol. 2018 Aug 16. doi: 10.1111/jgh.14381.
     PubMed    
     
     
     
137. WU SC, Chen WT, Muo CH, Hsu CY, et al
     A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
     J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
     PubMed     Abstract available
     
     
     
138. YAMADA N, Katano T, Hirata Y, Okada N, et al
     Serum Mac-2 Binding Protein Glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
     J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14438.
     PubMed     Abstract available
     
     
     
139. KENSTON SSF, Song X, Li Z, Zhao J, et al
     Mechanistic insight, diagnosis and treatment of ammonia induced hepatic encephalopathy.
     J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14408.
     PubMed     Abstract available
     
     
     
140. EUN HS, Cho SY, Lee BS, Kim S, et al
     Cytochrome P450 4A11 expression in tumor cells is a favorable prognostic factor for hepatocellular carcinoma patients.
     J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14406.
     PubMed     Abstract available
     
     
     
141. TARANTINO G, Porcu C, Arciello M, Andreozzi P, et al
     Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability.
     J Gastroenterol Hepatol. 2018;33:1511-1517.
     PubMed     Abstract available
     
     
     
142. WANG J, Ma L, Chen S, Xu L, et al
     Risk for the development of non-alcoholic fatty liver disease: A prospective study.
     J Gastroenterol Hepatol. 2018;33:1518-1523.
     PubMed     Abstract available
     
     
     July 2018
143. KIM TH, Lee HA, Seo YS, Lee YR, et al
     Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-beta-D-glucosaminidase.
     J Gastroenterol Hepatol. 2018 Jul 30. doi: 10.1111/jgh.14387.
     PubMed     Abstract available
     
     
     
144. HIRAOKA A, Kumada T, Ogawa C, Kariyama K, et al
     Proposed After Direct Acting Antivirals Recommendation for Surveillance (ADRES) score for scheduled ultrasonography surveillance for hepatocellular carcinoma: multicenter analysis.
     J Gastroenterol Hepatol. 2018 Jul 11. doi: 10.1111/jgh.14378.
     PubMed     Abstract available
     
     
     
145. YEAP SP, Harley H, Thompson R, Williamson KD, et al
     Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications.
     J Gastroenterol Hepatol. 2018 Jul 10. doi: 10.1111/jgh.14376.
     PubMed     Abstract available
     
     
     
146. WANG HW, Lai HC, Hu TH, Su WP, et al
     Modified FIB-4 index stratifies hepatocellular carcinoma risk in chronic hepatitis B patients on entecavir therapy.
     J Gastroenterol Hepatol. 2018 Jul 3. doi: 10.1111/jgh.14372.
     PubMed     Abstract available
     
     
     June 2018
147. HUANG CF, Wang SC, Yeh ML, Huang CI, et al
     Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
     J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14359.
     PubMed     Abstract available
     
     
     
148. LEE DH, Ahn JH, Chung JW, Kim YJ, et al
     Varices on CT is Surrogate of Clinically Significant Portal Hypertension and can Predict Survival in Compensated Cirrhosis Patients.
     J Gastroenterol Hepatol. 2018 Jun 14. doi: 10.1111/jgh.14319.
     PubMed     Abstract available
     
     
     
149. KAWAKAMI Y, Suzuki K, Miyake T, Hayashi Y, et al
     Hepatobiliary and Pancreatic: Hepatic alveolar echinococcosis mimics cholangiocarcinoma: Role of EUS-FNA.
     J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14279.
     PubMed    
     
     
     
150. WANG YF, Chen HQ
     Hepatobiliary and Pancreatic: Spontaneous cholecystocutaneous fistula.
     J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14285.
     PubMed    
     
     
     
151. LUO Q, Pang Z, Liu C, Liu X, et al
     Hepatobiliary and Pancreatic: Spontaneous hepatic hemorrhage caused by Ehlers-Danlos syndrome.
     J Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1111/jgh.14278.
     PubMed    
     
     
     
152. HONG J, Wang K, Yu Y
     Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor.
     J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14272.
     PubMed    
     
     
     
153. YAMASHIMA M, Ozawa E, Ohnita K, Tabata K, et al
     Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
     J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14274.
     PubMed    
     
     
     
154. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
     Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
     J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
     PubMed     Abstract available
     
     
     
155. LIU T, Xu L, Wang C, Chen K, et al
     Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
     J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
     PubMed     Abstract available
     
     
     
156. DONG XQ, Li J, Liu H, Wang YW, et al
     Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
     J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
     PubMed    
     
     
     
157. LIN YX, Fu YY, Cui T, Jia QB, et al
     Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
     J Gastroenterol Hepatol. 2018;33:1167.
     PubMed    
     
     
     
158. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
     Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
     J Gastroenterol Hepatol. 2018;33:1166.
     PubMed    
     
     
     
159. MAHADY SE, Adams LA
     Burden of non-alcoholic fatty liver disease in Australia.
     J Gastroenterol Hepatol. 2018;33 Suppl 1:1-11.
     PubMed     Abstract available
     
     
     
160. KOO BK, Joo SK, Kim D, Bae JM, et al
     Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2018;33:1277-1285.
     PubMed     Abstract available
     
     
     May 2018
161. AZUMA S, Kurita A, Yazumi S
     Hepatobiliary and Pancreatic: Burkitt lymphoma mimicking IgG4-related disease.
     J Gastroenterol Hepatol. 2018 May 28. doi: 10.1111/jgh.14276.
     PubMed    
     
     
     
162. KANG MK, Goo EJ, Kim SB, Kim KH, et al
     Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with distant cutaneous metastases to the face.
     J Gastroenterol Hepatol. 2018 May 16. doi: 10.1111/jgh.14091.
     PubMed    
     
     
     
163. KATO S, Kuwatani M, Kawakubo K, Sugiura R, et al
     Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis.
     J Gastroenterol Hepatol. 2018 May 15. doi: 10.1111/jgh.14088.
     PubMed    
     
     
     
164. YASUDA S, Ishigami M, Ishizu Y, Kuzuya T, et al
     Substitutions in interferon sensitivity determining region and hepatocarcinogenesis after hepatitis C virus eradication.
     J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14280.
     PubMed     Abstract available
     
     
     
165. UOJIMA H, Hidaka H, Tanaka Y, Inoue T, et al
     Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
     J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14277.
     PubMed     Abstract available
     
     
     
166. MANATSATHIT W, Samant H, Kapur S, Ingviya T, et al
     Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score, in detection of esophageal varices: systemic review and meta-analysis.
     J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14271.
     PubMed     Abstract available
     
     
     
167. KOBAYASHI M, Ryozawa S, Nagata K
     Hepatobiliary and Pancreatic: A case of pure squamous cell carcinoma of the gallbladder.
     J Gastroenterol Hepatol. 2018;33:976.
     PubMed    
     
     
     
168. LAINO ME, Ragucci M, Klimstra DS, Mannelli L, et al
     Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy.
     J Gastroenterol Hepatol. 2018;33:977.
     PubMed    
     
     
     
169. KAMIJO Y
     Is hepatic peroxisome proliferator-activated receptor alpha essential for the metabolic effects of fibrates?
     J Gastroenterol Hepatol. 2018;33:978-979.
     PubMed    
     
     
     
170. WONG GL
     Non-invasive assessments for liver fibrosis: The crystal ball we long for.
     J Gastroenterol Hepatol. 2018;33:1009-1015.
     PubMed     Abstract available
     
     
     
171. MIN YW, Kim Y, Gwak GY, Gu S, et al
     Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
     J Gastroenterol Hepatol. 2018;33:1053-1058.
     PubMed     Abstract available
     
     
     
172. TAMAI T, Taniyama O, Oda K, Kasai A, et al
     Reduction effect of the quantity of radiation exposure and contrast media by image support system in transarterial chemoembolization for the treatment of hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2018;33:1115-1122.
     PubMed     Abstract available
     
     
     
173. GUARINO M, Tortora R, de Stefano G, Coppola C, et al
     Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
     J Gastroenterol Hepatol. 2018;33:1123-1130.
     PubMed     Abstract available
     
     
     April 2018
174. HAMOIR C, de Vos M, Clinckart F, Nicaise G, et al
     Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.
     J Gastroenterol Hepatol. 2018 Apr 29. doi: 10.1111/jgh.14136.
     PubMed    
     
     
     
175. HABIB S, Patel N, Yarlagadda S, Hsu CH, et al
     Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients.
     J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14267.
     PubMed     Abstract available
     
     
     
176. SHIRAISHI Y, Imai K, Yamashita YI, Nakao Y, et al
     Hepatobiliary and Pancreatic: Segmental arterial mediolysis of pancreaticoduodenal artery accompanied by acute pancreatitis and duodenal obstruction.
     J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14138.
     PubMed    
     
     
     
177. ZHANG L, Gao H, Feng Y, Wang G, et al
     Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
     J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14084.
     PubMed    
     
     
     
178. CATERSON H, Liu K
     Hepatobiliary and Pancreatic: Rare hepatic vascular tumor presenting with hypertrophic osteoarthropathy.
     J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14087.
     PubMed    
     
     
     
179. SESHACHALAM VP, Sekar K, Hui KM
     Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
     J Gastroenterol Hepatol. 2018 Apr 19. doi: 10.1111/jgh.14262.
     PubMed     Abstract available
     
     
     
180. NIMRI L, Staikin K, Peri I, Yehuda-Shnaidman E, et al
     Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis.
     J Gastroenterol Hepatol. 2018 Apr 16. doi: 10.1111/jgh.14259.
     PubMed     Abstract available
     
     
     
181. KODAMA K, Kawaoka T, Aikata H, Uchikawa S, et al
     Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
     J Gastroenterol Hepatol. 2018 Apr 12. doi: 10.1111/jgh.14152.
     PubMed     Abstract available
     
     
     
182. LIN YX, Hu HJ, Li FY, Jia QB, et al
     Hepatobiliary and Pancreatic: Biliary reoperation for recurrent intrahepatic stones in patients with polysplenia syndrome.
     J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14137.
     PubMed    
     
     
     
183. YANG MJ, Kim JH, Kim DJ, Hwang JC, et al
     Hepatobiliary and Pancreatic: EUS-guided reintervention for extraluminal stent migration after EUS-guided hepaticogastrostomy.
     J Gastroenterol Hepatol. 2018;33:772.
     PubMed    
     
     
     
184. KANG MK, Kim TN
     Hepatobiliary and Pancreatic: Hepatocellular carcinoma diagnosed by proptosis due to metastatic orbital mass.
     J Gastroenterol Hepatol. 2018;33:773.
     PubMed    
     
     
     
185. MIYATA T, Tajima H, Hirata M, Nakanuma SI, et al
     Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
     J Gastroenterol Hepatol. 2018;33:950-957.
     PubMed     Abstract available
     
     
     
186. SONG DS, Kim TY, Kim DJ, Kim HY, et al
     Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.
     J Gastroenterol Hepatol. 2018;33:900-909.
     PubMed     Abstract available
     
     
     March 2018
187. CHAN WK, Mustapha NRN, Mahadeva S, Wong VW, et al
     Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
     J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14150.
     PubMed     Abstract available
     
     
     
188. TANDON P, Bishay K, Fisher S, Yelle D, et al
     Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
     J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
     PubMed     Abstract available
     
     
     
189. PARK SW, Jun CH, Choi SK, Kim HJ, et al
     Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
     J Gastroenterol Hepatol. 2018;33:562.
     PubMed    
     
     
     
190. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
     Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
     J Gastroenterol Hepatol. 2018;33:563.
     PubMed    
     
     
     
191. PAPALUCA T, Gow P
     Terlipressin: Current and emerging indications in chronic liver disease.
     J Gastroenterol Hepatol. 2018;33:591-598.
     PubMed     Abstract available
     
     
     
192. ABE K, Takahashi A, Imaizumi H, Hayashi M, et al
     Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease.
     J Gastroenterol Hepatol. 2018;33:733-740.
     PubMed     Abstract available
     
     
     February 2018
193. KIM TH, Ku DH, Um SH, Lee HA, et al
     How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
     J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
     PubMed     Abstract available
     
     
     
194. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
     A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
     J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
     PubMed     Abstract available
     
     
     
195. YAMADA T, Nakanishi Y, Okamura K, Tsuchikawa T, et al
     Impact of serum CA19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
     J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14124.
     PubMed     Abstract available
     
     
     
196. DOI H, Hayashi E, Arai J, Tojo M, et al
     Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
     J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
     PubMed     Abstract available
     
     
     
197. HACZEYNI F, Yeh MM, Ioannou GN, Leclercq IA, et al
     Mouse Models Of Nonalcoholic Steatohepatitis: A Reflection On Recent Literature.
     J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14122.
     PubMed     Abstract available
     
     
     
198. OKUNO N, Hara K, Mizuno N, Kuwahara T, et al
     Efficacy of the 6-mm FCSEMS during EUS-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult ERCP: a prospective clinical study.
     J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14112.
     PubMed     Abstract available
     
     
     
199. WANG Q, Wang G, Wang Y, Liu C, et al
     ALKBH3 expression is associated with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117.
     PubMed     Abstract available
     
     
     
200. ZHANG LH, Tai Y, Tong H, Lei XJ, et al
     Hepatobiliary and Pancreatic: Rare cause of obstructive jaundice by Trichosporon asahii.
     J Gastroenterol Hepatol. 2018;33:338.
     PubMed    
     
     
     
201. JAISWAL P, Jaiswal R, Attar BM, Dedania B, et al
     Hepatobiliary and Pancreatic: Massive hepatic cystic echinococcosis compressing inferior vena cava.
     J Gastroenterol Hepatol. 2018;33:339.
     PubMed    
     
     
     
202. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
     Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
     J Gastroenterol Hepatol. 2018;33:511-517.
     PubMed     Abstract available
     
     
     
203. DUAN X, Meng Q, Wang C, Liu Z, et al
     Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
     J Gastroenterol Hepatol. 2018;33:533-542.
     PubMed     Abstract available
     
     
     January 2018
204. MANCEBO A, Varela M, Gonzalez-Dieguez ML, Navascues CA, et al
     Incidence and Risk Factors Associated with Hepatocellular Carcinoma Surveillance Failure.
     J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14108.
     PubMed     Abstract available
     
     
     
205. ZHANG F, Zhang J, Li X, Li B, et al
     The Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration.
     J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14110.
     PubMed     Abstract available
     
     
     
206. KAO JH, Yu ML, Chen CY, Peng CY, et al
     Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
     J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
     PubMed     Abstract available
     
     
     
207. KIM NH, Lee T, Cho YK, Kim BI, et al
     Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
     J Gastroenterol Hepatol. 2018 Jan 3. doi: 10.1111/jgh.14083.
     PubMed     Abstract available
     
     
     
208. FANG X, Liu LW, Dong J, Zhang J, et al
     A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
     J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
     PubMed     Abstract available
     
     
     
209. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
     Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
     J Gastroenterol Hepatol. 2018;33:9.
     PubMed    
     
     
     
210. CRIMI F, Guido M, Pomerri F
     Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
     J Gastroenterol Hepatol. 2018;33:8.
     PubMed    
     
     
     
211. NAKAJIMA S, Tanaka H, Sawada K, Hayashi H, et al
     Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2018;33:283-290.
     PubMed     Abstract available
     
     
     
212. KAKISAKA K, Suzuki Y, Kataoka K, Okada Y, et al
     Predictive formula of coma onset and prothrombin time to distinguish patients who recover from acute liver injury.
     J Gastroenterol Hepatol. 2018;33:277-282.
     PubMed     Abstract available
     
     
     
213. EDA K, Mizuochi T, Iwama I, Inui A, et al
     Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan.
     J Gastroenterol Hepatol. 2018;33:264-269.
     PubMed     Abstract available
     
     
     
214. DE JONGE P, de Man RA, van Buuren HR
     Gastrointestinal: Rare cause of hematemesis initially presenting as a bleeding gastric Dieulafoy's lesion.
     J Gastroenterol Hepatol. 2018;33:6.
     PubMed    
     
     
     
215. CHITTURI S, Wong VW, Chan WK, Wong GL, et al
     The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
     J Gastroenterol Hepatol. 2018;33:86-98.
     PubMed    
     
     
     December 2017
216. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
     Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
     J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
     PubMed     Abstract available
     
     
     
217. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
     Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
     J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
     PubMed     Abstract available
     
     
     
218. ZHOU LY, Ma YJ, Tian F
     Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.
     J Gastroenterol Hepatol. 2017;32:1913.
     PubMed    
     
     
     
219. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
     Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
     J Gastroenterol Hepatol. 2017;32:1989-1997.
     PubMed     Abstract available
     
     
     November 2017
220. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
     Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
     PubMed     Abstract available
     
     
     
221. LI G, Brocker CN, Xie C, Yan T, et al
     Hepatic PPARalpha mediates the major metabolic effects of Wy-14643.
     J Gastroenterol Hepatol. 2017 Nov 15. doi: 10.1111/jgh.14046.
     PubMed     Abstract available
     
     
     
222. SCHLEVOGT B, Rehkamper J, Hild B, Schmidt HH, et al
     Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.
     J Gastroenterol Hepatol. 2017;32:1795.
     PubMed    
     
     
     
223. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
     Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
     J Gastroenterol Hepatol. 2017;32:1867-1872.
     PubMed     Abstract available
     
     
     
224. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
     Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
     J Gastroenterol Hepatol. 2017;32:1852-1858.
     PubMed     Abstract available
     
     
     October 2017
225. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
     Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
     J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
     PubMed     Abstract available
     
     
     
226. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
     Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
     J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
     PubMed     Abstract available
     
     
     
227. CHOE EY, Lee YH, Choi YJ, Huh BW, et al
     Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.
     J Gastroenterol Hepatol. 2017 Oct 8. doi: 10.1111/jgh.14011.
     PubMed     Abstract available
     
     
     
228. SHI SH, Feng XN, Wang ZY, Sun K, et al
     Pyogenic liver abscess related to intrahepatic bile duct stones: difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
     J Gastroenterol Hepatol. 2017 Oct 6. doi: 10.1111/jgh.14010.
     PubMed     Abstract available
     
     
     
229. DING F, Li Q, Duan X, Ye J, et al
     Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
     J Gastroenterol Hepatol. 2017;32:1666.
     PubMed    
     
     
     
230. GILES H, Ross A, Gearry RB
     Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
     J Gastroenterol Hepatol. 2017;32:1663.
     PubMed    
     
     
     
231. NGUYEN BD
     Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
     J Gastroenterol Hepatol. 2017;32:1667.
     PubMed    
     
     
     
232. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
     Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
     J Gastroenterol Hepatol. 2017;32:1668-1678.
     PubMed     Abstract available
     
     
     
233. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
     Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
     J Gastroenterol Hepatol. 2017;32:1746-1753.
     PubMed     Abstract available
     
     
     
234. LIN YJ, Gao XM, Pan WW, Gao S, et al
     A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
     J Gastroenterol Hepatol. 2017;32:1739-1745.
     PubMed     Abstract available
     
     
     September 2017
235. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
     Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
     J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
     PubMed     Abstract available
     
     
     
236. SEO YS, Park SY, Kim MY, Kim SG, et al
     Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
     J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
     PubMed     Abstract available
     
     
     
237. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
     Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
     J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
     PubMed     Abstract available
     
     
     
238. ESO Y, Takai A, Arasawa S, Ueda Y, et al
     Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guerin disease.
     J Gastroenterol Hepatol. 2017;32:1538.
     PubMed    
     
     
     
239. LIU PC, Wu MS, Hsieh MC, Suk FM, et al
     Hepatobiliary and Pancreatic: Development from gallbladder stone to gallstone ileus.
     J Gastroenterol Hepatol. 2017;32:1539.
     PubMed    
     
     
     
240. LV XH, Wang CH, Xie Y
     Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
     J Gastroenterol Hepatol. 2017;32:1540-1547.
     PubMed     Abstract available
     
     
     
241. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
     Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
     J Gastroenterol Hepatol. 2017;32:1617-1623.
     PubMed     Abstract available
     
     
     
242. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
     Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
     J Gastroenterol Hepatol. 2017;32:1587-1597.
     PubMed     Abstract available
     
     
     August 2017
243. GERAGE AM, Ritti-Dias RM, Balagopal B, de Oliveira Conceicao RD, et al
     Physical activity levels and hepatic steatosis: a longitudinal follow up study in adults.
     J Gastroenterol Hepatol. 2017 Aug 30. doi: 10.1111/jgh.13965.
     PubMed     Abstract available
     
     
     
244. LEE EC, Park SJ, Han SS, Shim JR, et al
     Risk Prediction of Post-Hepatectomy Liver Failure in Patients with Perihilar Cholangiocarcinoma.
     J Gastroenterol Hepatol. 2017 Aug 26. doi: 10.1111/jgh.13966.
     PubMed     Abstract available
     
     
     
245. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
     Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
     J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
     PubMed     Abstract available
     
     
     
246. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
     Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
     J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
     PubMed     Abstract available
     
     
     
247. HO CM, Wu CH, Liau JY
     Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
     J Gastroenterol Hepatol. 2017;32:1424.
     PubMed    
     
     
     
248. MATSUMURA K, Hashimoto D, Umezaki N, Nakagawa S, et al
     Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
     J Gastroenterol Hepatol. 2017;32:1425.
     PubMed    
     
     
     July 2017
249. DE SANTIS A, Nardelli S, Bassanelli C, Lupo M, et al
     The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
     J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907.
     PubMed     Abstract available
     
     
     
250. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
     Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
     J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
     PubMed     Abstract available
     
     
     
251. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
     Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
     J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
     PubMed     Abstract available
     
     
     
252. ZHONG X, Liu H
     Honokiol attenuates Diet-Induced Nonalcoholic Steatohepatitis by regulating macrophage polarization through activating PPARgamma.
     J Gastroenterol Hepatol. 2017 Jul 2. doi: 10.1111/jgh.13853.
     PubMed     Abstract available
     
     
     
253. COSTA JM, Costa D, Vieira F, Rolanda C, et al
     Hepatobiliary and Pancreatic: Giant hepatomegaly from hepatic hemagiomatosis.
     J Gastroenterol Hepatol. 2017;32:1285.
     PubMed    
     
     
     
254. AGARWAL J, Hasan A, Mehrotra M
     Hepatobiliary and Pancreatic: Hepatogastric fistula.
     J Gastroenterol Hepatol. 2017;32:1284.
     PubMed    
     
     
     
255. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
     Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
     J Gastroenterol Hepatol. 2017;32:1378-1386.
     PubMed     Abstract available
     
     
     
256. LOONG TC, Wei JL, Leung JC, Wong GL, et al
     Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2017;32:1363-1369.
     PubMed     Abstract available
     
     
     June 2017
257. KIM BS, Seo YS, Kim YS, Lee CH, et al
     Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
     J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
     PubMed     Abstract available
     
     
     
258. FUJITA K, Niki T, Nomura T, Oura K, et al
     Serum galectin-9 levels are correlated to liver fibrosis regardless of chronic inflammation or hepatocellular carcinoma complications.
     J Gastroenterol Hepatol. 2017 Jun 15. doi: 10.1111/jgh.13851.
     PubMed     Abstract available
     
     
     
259. SZKLARUK J, Kaya D, Wei W
     Evaluation of the Added Value of Imaging the Pelvis in Patients with Hepatocellular Cancer.
     J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13847.
     PubMed     Abstract available
     
     
     
260. KIM BH, Lim YS, Kim EY, Kong HJ, et al
     Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population.
     J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13848.
     PubMed     Abstract available
     
     
     
261. ZHANG X, Li J, Shen F, Lau WY, et al
     Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
     PubMed     Abstract available
     
     
     
262. LING QA, Yo J, Gerstenmaier JF, Kemp W, et al
     Hepatobiliary and Pancreatic: Hepatic and mesenteric aneurysms with biloma formation.
     J Gastroenterol Hepatol. 2017;32:1134.
     PubMed    
     
     
     
263. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
     Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
     J Gastroenterol Hepatol. 2017;32:1240-1249.
     PubMed     Abstract available
     
     
     May 2017
264. LIU CH, Liu CJ, Hong CM, Su TH, et al
     A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
     J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
     PubMed     Abstract available
     
     
     
265. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
     Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
     J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
     PubMed     Abstract available
     
     
     
266. KIM JH, Lim KS, Min YW, Lee H, et al
     Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
     J Gastroenterol Hepatol. 2017;32:1064-1070.
     PubMed     Abstract available
     
     
     
267. MAIA L, Ferreira JM, Pedroto I
     Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
     J Gastroenterol Hepatol. 2017;32:948.
     PubMed    
     
     
     
268. JUN DW, Kim SG, Park SH, Jin SY, et al
     External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
     J Gastroenterol Hepatol. 2017;32:1094-1099.
     PubMed     Abstract available
     
     
     
269. PARKER R, Hodson J, Rowe IAC
     Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
     J Gastroenterol Hepatol. 2017;32:950-956.
     PubMed     Abstract available
     
     
     
270. RASHID HO, Kim HK, Junjappa R, Kim HR, et al
     Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1alpha and beta-dependent decay and miRNA.
     J Gastroenterol Hepatol. 2017;32:981-991.
     PubMed     Abstract available
     
     
     April 2017
271. ITO K, Murotani K, Nakade Y, Inoue T, et al
     Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
     J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
     PubMed     Abstract available
     
     
     
272. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
     Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
     J Gastroenterol Hepatol. 2017;32:738.
     PubMed    
     
     
     
273. LOURENCO LC, Horta DV, Reis J
     Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
     J Gastroenterol Hepatol. 2017;32:739.
     PubMed    
     
     
     
274. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
     ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
     J Gastroenterol Hepatol. 2017;32:879-886.
     PubMed     Abstract available
     
     
     
275. NJEI B, McCarty TR, Laine L
     Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
     J Gastroenterol Hepatol. 2017;32:852-858.
     PubMed     Abstract available
     
     
     March 2017
276. JIANG T, Du F, Qin N, Lu Q, et al
     Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
     J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
     PubMed     Abstract available
     
     
     
277. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
     Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
     J Gastroenterol Hepatol. 2017;32:547.
     PubMed    
     
     
     
278. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
     Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
     J Gastroenterol Hepatol. 2017;32:546.
     PubMed    
     
     
     
279. ZENG XQ, Ma LL, Tseng YJ, Chen J, et al
     Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: A randomized pilot study.
     J Gastroenterol Hepatol. 2017;32:631-638.
     PubMed     Abstract available
     
     
     February 2017
280. CHONG CC, Wong GL, Chan AW, Wong VW, et al
     Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study.
     J Gastroenterol Hepatol. 2017;32:506-514.
     PubMed     Abstract available
     
     
     
281. SHI KQ, Cai YJ, Lin Z, Dong JZ, et al
     Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
     J Gastroenterol Hepatol. 2017;32:497-505.
     PubMed     Abstract available
     
     
     January 2017
282. POLLOCK G, Minuk GY
     Diagnostic Considerations for Cholestatic Liver Disease.
     J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
     PubMed     Abstract available
     
     
     
283. RATHOD K, Deshmukh H, Shukla A, Popat B, et al
     Endovascular treatment of Budd-Chiari syndrome: Single center experience.
     J Gastroenterol Hepatol. 2017;32:237-243.
     PubMed     Abstract available
     
     
     
284. CHOI HJ, Moon JH, Kim HK, Lee YN, et al
     KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
     J Gastroenterol Hepatol. 2017;32:154-162.
     PubMed     Abstract available
     
     
     October 2016
285. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
     Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
     J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
     PubMed     Abstract available
     
     
     July 2016
286. PARK TY, Lee SK, Nam K, Oh D, et al
     Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
     J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
     PubMed     Abstract available
     
     
     May 2016
287. OGURA T, Onda S, Takagi W, Sano T, et al
     Clinical utility of Endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention procedure for high-grade hilar stricture.
     J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13437.
     PubMed     Abstract available
     
     
     December 2015
288. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
     Performance of magnetic resonance elastography in primary sclerosing cholangitis.
     J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
     PubMed     Abstract available
     
     
     November 2015
289. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
     The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
     J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
     PubMed     Abstract available
     
     
     
290. KIM Y, Lee EJ, Jang HK, Kim CH, et al
     Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
     J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
     PubMed     Abstract available
     
     
     October 2015
291. WANG D, Wang Q, Yin J, Dong R, et al
     Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
     J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: